DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,251,000 | +38.9% | 855,713 | +157.2% | 1.04% | +52.2% |
| Q2 2021 | $12,417,000 | +46.0% | 332,713 | 0.0% | 0.68% | +41.0% |
| Q1 2021 | $8,507,000 | +16.4% | 332,713 | +0.3% | 0.48% | +26.6% |
| Q4 2020 | $7,310,000 | +22.5% | 331,813 | 0.0% | 0.38% | +16.8% |
| Q3 2020 | $5,969,000 | -29.2% | 331,813 | 0.0% | 0.33% | -35.2% |
| Q2 2020 | $8,428,000 | +38.3% | 331,813 | 0.0% | 0.51% | -0.8% |
| Q1 2020 | $6,095,000 | -16.6% | 331,813 | 0.0% | 0.51% | +26.9% |
| Q4 2019 | $7,310,000 | +53.4% | 331,813 | 0.0% | 0.40% | +26.8% |
| Q3 2019 | $4,765,000 | -8.8% | 331,813 | 0.0% | 0.32% | +24.8% |
| Q2 2019 | $5,226,000 | -28.8% | 331,813 | -33.8% | 0.25% | -17.0% |
| Q1 2019 | $7,338,000 | +37.0% | 500,913 | 0.0% | 0.31% | +7.4% |
| Q4 2018 | $5,355,000 | -29.9% | 500,913 | 0.0% | 0.28% | -7.8% |
| Q3 2018 | $7,644,000 | +24.6% | 500,913 | 0.0% | 0.31% | +26.1% |
| Q2 2018 | $6,136,000 | +28.1% | 500,913 | 0.0% | 0.24% | +19.5% |
| Q1 2018 | $4,789,000 | +5.9% | 500,913 | 0.0% | 0.20% | +5.1% |
| Q4 2017 | $4,523,000 | +57.0% | 500,913 | 0.0% | 0.20% | +61.2% |
| Q3 2017 | $2,880,000 | +81.4% | 500,913 | 0.0% | 0.12% | +63.5% |
| Q2 2017 | $1,588,000 | -3.0% | 500,913 | +4.0% | 0.07% | -3.9% |
| Q1 2017 | $1,637,000 | +259.0% | 481,519 | +204.2% | 0.08% | +196.2% |
| Q4 2016 | $456,000 | -71.0% | 158,279 | -40.9% | 0.03% | -71.4% |
| Q3 2016 | $1,575,000 | +95.9% | 267,890 | 0.0% | 0.09% | +49.2% |
| Q2 2016 | $804,000 | -44.0% | 267,890 | 0.0% | 0.06% | -45.0% |
| Q1 2016 | $1,436,000 | -54.8% | 267,890 | 0.0% | 0.11% | -37.3% |
| Q4 2015 | $3,180,000 | +44.6% | 267,890 | 0.0% | 0.18% | +67.0% |
| Q3 2015 | $2,199,000 | +123.0% | 267,890 | +278.9% | 0.11% | +140.9% |
| Q2 2015 | $986,000 | – | 70,706 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |